Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An Author's Perspective
    • Ask the Experts
    • Bioanalysis articles
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Spotlights
    • Tech Digest
    • T&F journals

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Awareness
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Professional development
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Biosensors
      • Chromatography
      • Flow Cytometry
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

Welcome to Bioanalysis ZONE

27 APR 2026 NEWS
Stretching the limit: new technique improves measurement of cell elasticity
27 APR 2026 WEBINAR
Beyond context of use: smarter LC–MS strategies for biomarker success
23 APR 2026 NEWS
Jessica Bridges Weaver named as a 2026 Women in Business award winner
21 APR 2026 EXPERT OPINION
A loaded tip
20 APR 2026 NEWS
Unlocking the inner workings of cancer cells
16 APR 2026 NEWS
Biochip uses AI to identify genetic markers in 20 minutes
1 / 6
13 APR 2026 EXPERT OPINION / ARTICLE

The science of bioanalytical training

7 APR 2026 EXPERT OPINION / ARTICLE

The one-trial era: what the FDA’s shift signals for the future of drug development

7 APR 2026 INTERVIEWS / VIDEO

Part three: Regulatory considerations, validation strategies and emerging trends: qPCR/dPCR/ddPCR


Journal Content

10 MAR 2026 Review / Bioanalysis

Progress and promise of pharmacodynamic biomarkers: novel strategies and assay considerations in...

22 JAN 2026 Perspective / Bioanalysis

Managing the transition: switching bioanalytical laboratories during a clinical trial – a...

12 JAN 2026 Methodology / Bioanalysis

FALCON-qPCR: a new method for the quantification of oxidative lesions in mitochondrial...

18 DEC 2025 Interview / Bioanalysis

WRIB poster award winners 2025

16 DEC 2025 Research Article / Bioanalysis

Addressing nonspecific interactions in a Gyrolab anti-drug antibody (ADA) assay: a case...

11 DEC 2025 Editorial / Bioanalysis

The complexities of oligonucleotide therapeutics: analytical challenges and opportunities within early drug...

3 DEC 2025 Research Article / Bioanalysis

Improving sensitivity and drug tolerance of assays for neutralizing anti-drug antibodies to...

31 OCT 2025 Abstracts / Bioanalysis

Comparing capillary blood collection technologies: assessing patient experience, device performance & clinical...

9 OCT 2025 Review / Bioanalysis

Patient centric blood sampling and analysis for diagnostics and laboratory medicine

Latest Articles Current Issue List of Issues

Featured

IN THE ZONE

In the Zone: biomarkers in drug development – why strategy matters

SPOTLIGHT

Flow cytometry in bioanalysis – precision, partnership and the power of innovation

INTERVIEWS / PODCAST

Trends, tools and transformation: the evolution of flow cytometry in bioanalysis

INTERVIEWS / PODCAST

115 analytes, one panel: a conversation on innovation in biomarker discovery

IN THE ZONE

Mission multiplex: mastering your biomarker journey

BIOMARKERS / PODCAST

Exploring biomarker testing in clinical research

IN THE ZONE

In the Zone: bioanalytical methods for quantifying oligonucleotides

INTERVIEWS / PODCAST

First void urine: revolutionizing potential non-invasive biomarker collection for clinical diagnostics

IN THE ZONE

In the Zone: AAV characterization and analysis for gene therapy

INTERVIEWS / PODCAST

LC–MS/MS for quantitation of protein biomarkers

Must Watch

MS (LC–MS/MS, HRMS, IMS) / WEBINAR

Beyond context of use: smarter LC–MS strategies for biomarker success

7 APR 2026 CELL AND GENE THERAPIES / VIDEO

Part three: Regulatory considerations, validation strategies and emerging trends: qPCR/dPCR/ddPCR

18 MAR 2026 ANTIBODIES | ADCS / WEBINAR

Overcoming challenges for preclinical bioanalysis of ADC therapeutics

16 MAR 2026 CELL AND GENE THERAPIES / VIDEO

Part two: Applications of PCR-based methods in gene therapy development

INTERVIEWS / VIDEO

Joe Eckenrode on mass spectrometry for measuring receptor occupancy

ANTIBODIES | ADCS / WEBINAR

LC–MS strategies for advanced modalities: ADC, AOC, multidomain and RNA therapeutics

DRUG DEVELOPMENT / WEBINAR

Turning down the volume: advancing microsampling within bioanalysis

DATA PROCESSING AND INTERPRETATION / WEBINAR

Panel discussion: Flow cytometry in bioanalysis

CELL AND GENE THERAPIES / VIDEO

Part one: Technical comparisons between qPCR/dPCR/ddPCR

ANTIBODIES | ADCS / VIDEO

BioAgilytix's LC/MS global expansion with Lynn Kamen and Dave Beyerlein

What's Trending?

MS (LC–MS/MS, HRMS, IMS) / ARTICLE

eBook: Precision bioanalysis for every molecule

EXPERT OPINION / ARTICLE

The one-trial era: what the FDA’s shift signals for the future of drug development

INTERVIEWS / VIDEO

Part three: Regulatory considerations, validation strategies and emerging trends: qPCR/dPCR/ddPCR

IN THE ZONE

In the Zone: biomarkers in drug development – why strategy matters

EXPERT OPINION / ARTICLE

The science of bioanalytical training

ARTICLE / ARTICLE

Validation of a 25-color spectral flow cytometry assay for immunoprofiling of human whole blood samples from clinical trials

  • About
  • Accessibility
  • Advertising & Sponsorship
  • Contact Us
  • Editorial Policies
  • Permissions
  • Whitelist Emails
  • Zone Leaders

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone